Abbott Laboratories (ABT) vs Dover Corporation (DOV)
A side-by-side comparison of Abbott Laboratories and Dover Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: ABT is classified in Healthcare; DOV is classified in Industrials. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
ABT
Abbott Laboratories
$107.32HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
DOV
Dover Corporation
$203.08IndustrialsDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — ABT vs DOV
growth of $100 · dividends reinvested · last 30yABT +1921.4%DOV +2249.0%DOV compounded faster
ABT DOV
ABT vs DOV: by the numbers
- •ABT is the larger company ($186.93B vs $27.35B market cap).
- •DOV trades at the lower trailing earnings multiple (24.86 vs 33.60 P/E), one valuation lens rather than an overall verdict.
- •DOV converts more revenue to profit (13.48% vs 11.65% net margin).
- •ABT grew revenue faster over the past five years (2.98% vs 2.54% CAGR).
- •ABT pays the higher dividend yield (2.34% vs 1.01%).
Metrics side by side
Valuation
| Metric | ABT | DOV |
|---|---|---|
| P/E ratio | 33.60 | 24.86 |
| Forward P/E | 18.96 | 19.27 |
| P/S ratio | 3.91 | 3.31 |
| P/B ratio | 3.51 | 3.62 |
| PEG ratio | 4.09 | 2.27 |
| EV / EBITDA | 21.21 | 17.14 |
| FCF yield | 4.04% | 4.21% |
Profitability
| Metric | ABT | DOV |
|---|---|---|
| Gross margin | 56.80% | 39.58% |
| Operating margin | 17.03% | 16.87% |
| Net margin | 11.65% | 13.48% |
| ROE | 10.42% | 14.73% |
| ROIC | 8.43% | 9.40% |
Dividends
| Metric | ABT | DOV |
|---|---|---|
| Dividend yield | 2.34% | 1.01% |
| Payout ratio | 65.24% | 26.10% |
Growth (annualized)
| Metric | ABT | DOV |
|---|---|---|
| Revenue CAGR (5Y) | 2.98% | 2.54% |
| EPS CAGR (5Y) | 8.22% | 10.95% |
| FCF CAGR (5Y) | 5.26% | 2.56% |
| Total return CAGR (5Y) | -0.78% | 6.04% |
Frequently asked
- Which has the lower trailing P/E, ABT or DOV?
- DOV has the lower trailing P/E: ABT trades at 33.60 and DOV at 24.86. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABT or DOV?
- Over the past five years, ABT grew revenue faster — ABT at a 2.98% CAGR versus DOV at 2.54%.
- Does ABT or DOV pay a bigger dividend?
- ABT yields 2.34% and DOV yields 1.01% based on trailing dividends and the latest price.
- Is ABT or DOV more profitable?
- DOV runs the higher net margin — ABT at 11.65% versus DOV at 13.48%.
- How have ABT and DOV total returns compared?
- Over the past 10 years, ABT delivered 11.19% and DOV delivered 15.37% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Abbott Laboratories P/E ratioDover P/E ratioAbbott Laboratories dividend yieldDover dividend yieldAbbott Laboratories ROEDover ROEAbbott Laboratories operating marginDover operating marginAbbott Laboratories revenue growthDover revenue growthAbbott Laboratories free cash flowDover free cash flow
Abbott Laboratories & Dover appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.